Invesco India Small Cap Fund

A Small Cap Fund scheme from Invesco Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF205K013T3).

NAV ₹56.0600 on 16 November 2026.

Expense ratio

Total expense ratio 0.64% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.41%, brokerage 0.05%, transaction costs 0.00%, statutory levies including GST 0.18%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year18.8%18.0%-14.2%0.650.66
3 years21.1%18.2%-23.4%0.780.70
5 years19.9%17.0%-23.4%0.760.67

Too little NAV history for the 10-year figures.

Category rank: 3rd of 27 Direct-Growth funds in Small Cap Fund, by 3-year Sortino ratio.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 99.7% of the portfolio.

  1. Sai Life Sciences Limited — 5.40%
  2. ETERNAL LIMITED — 4.22%
  3. Aditya Infotech Limited — 3.90%
  4. Max Healthcare Institute Limited — 3.45%
  5. Prestige Estates Projects Limited — 3.34%
  6. Amber Enterprises India Limited — 3.29%
  7. Krishna Institute of Medical Sciences Limited — 3.20%
  8. InterGlobe Aviation Limited — 2.98%
  9. Dr. Agarwal's Health Care Limited — 2.38%
  10. Craftsman Automation Limited — 2.28%

Plans

Other funds in Small Cap Fund

All 37 funds in Small Cap Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.